Szychlinska Marta Anna, Calabrese Giovanna, Ravalli Silvia, Dolcimascolo Anna, Castrogiovanni Paola, Fabbi Claudia, Puglisi Caterina, Lauretta Giovanni, Di Rosa Michelino, Castorina Alessandro, Parenti Rosalba, Musumeci Giuseppe
Department of Biomedical and Biotechnological Sciences, Anatomy, Histology and Movement Sciences Section, School of Medicine, University of Catania, 95123 Catania, Italy.
Department of Biomedical and Biotechnological Sciences, Physiology Section, School of Medicine, University of Catania, 95123 Catania, Italy.
Materials (Basel). 2020 May 21;13(10):2369. doi: 10.3390/ma13102369.
The management of chondral defects represents a big challenge because of the limited self-healing capacity of cartilage. Many approaches in this field obtained partial satisfactory results. Cartilage tissue engineering, combining innovative scaffolds and stem cells from different sources, emerges as a promising strategy for cartilage regeneration. The aim of this study was to evaluate the capability of a cell-free collagen I-based scaffold to promote cartilaginous repair after orthotopic implantation in vivo. Articular cartilage lesions (ACL) were created at the femoropatellar groove in rat knees and cell free collagen I-based scaffolds (S) were then implanted into right knee defect for the ACL-S group. No scaffold was implanted for the ACL group. At 4-, 8- and 16-weeks post-transplantation, degrees of cartilage repair were evaluated by morphological, histochemical and gene expression analyses. Histological analysis shows the formation of fibrous tissue, at 4-weeks replaced by a tissue resembling the calcified one at 16-weeks in the ACL group. In the ACL-S group, progressive replacement of the scaffold with the newly formed cartilage-like tissue is shown, as confirmed by Alcian Blue staining. Immunohistochemical and quantitative real-time PCR (qRT-PCR) analyses display the expression of typical cartilage markers, such as collagen type I and II ( and ), and . The results of this study display that the collagen I-based scaffold is highly biocompatible and able to recruit host cells from the surrounding joint tissues to promote cartilaginous repair of articular defects, suggesting its use as a potential approach for cartilage tissue regeneration.
由于软骨的自我修复能力有限,软骨缺损的治疗是一项巨大的挑战。该领域的许多方法都取得了部分令人满意的结果。结合创新支架和不同来源干细胞的软骨组织工程,成为一种有前景的软骨再生策略。本研究的目的是评估一种无细胞的I型胶原支架在体内原位植入后促进软骨修复的能力。在大鼠膝关节的股骨髌股沟处制造关节软骨损伤(ACL),然后将无细胞的I型胶原支架(S)植入ACL-S组右膝缺损处。ACL组不植入支架。在移植后4周、8周和16周,通过形态学、组织化学和基因表达分析评估软骨修复程度。组织学分析显示,ACL组在4周时形成纤维组织,在16周时被类似钙化组织的组织取代。在ACL-S组中,如阿尔新蓝染色所证实的,支架逐渐被新形成的软骨样组织取代。免疫组织化学和定量实时PCR(qRT-PCR)分析显示了典型软骨标志物的表达,如I型和II型胶原(以及 和 )。本研究结果表明,I型胶原支架具有高度生物相容性,能够从周围关节组织募集宿主细胞,促进关节缺损的软骨修复,表明其可作为软骨组织再生的潜在方法。